Memorializing Governor Kathy Hochul to proclaim the month of May 2026, as Hepatitis B Awareness Month in the State of New York
This resolution memorializes Governor Kathy Hochul to proclaim May 2026 as Hepatitis B Awareness Month in New York State. It is a commemorative measure, not a regulatory bill, and its purpose is to elevate public awareness of hepatitis B, its transmission, symptoms, diagnosis, treatment, and prevention. The resolution emphasizes the seriousness of hepatitis B as a liver infection that can become chronic and lead to cirrhosis or liver cancer, and it highlights the fact that many people with the virus are unaware they are infected.
The resolution specifically points to New York’s high hepatitis B burden, including a significant prevalence statewide and a large concentration of cases in Queens County. It also underscores the importance of infant vaccination, noting the historical success of the universal hepatitis B birth dose recommendation in reducing childhood infections and deaths. In addition, it references gaps in screening, treatment, and linkage to care, arguing that greater awareness and access to services are needed to protect public health in New York.
Because this is a Senate resolution, it does not amend the Public Health Law or create new statutory requirements. Its legal effect is limited to requesting a gubernatorial proclamation and encouraging public education and awareness activities. The practical impact is symbolic and promotional, but it may support outreach by public health agencies, healthcare providers, and community organizations focused on hepatitis B screening, vaccination, and treatment.
The overall sentiment is strongly supportive and public-health oriented. The resolution presents hepatitis B awareness as an urgent and beneficial cause, and the absence of recorded opposition, committee debate, or votes suggests no visible controversy in the available record. The tone is preventive and educational, with emphasis on protecting infants, reducing undiagnosed infections, and improving access to care.
No formal points of contention are reflected in the available bill history, since there are no committee transcripts or recorded votes. The only potentially sensitive policy backdrop mentioned in the text is the recent change in national immunization guidance regarding the universal hepatitis B birth dose, which the resolution implicitly critiques by reaffirming the value of universal vaccination. Any disagreement would likely center on vaccination policy, screening practices, or the scope of public health messaging, but none is documented in the provided materials.